VIVIAN FELDMAN: Open Payments
NPI 1437792934 · NEW YORK, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,773 in 70 payments from 17 companies in 2025. Trend: 2023 $1,410 · 2024 $2,947 · 2025 $1,773
Food & beverage: $1,773
| Company | Payments | Amount |
|---|---|---|
| Abbott Laboratories | 11 | $449 |
| Novartis Pharmaceuticals Corporation | 11 | $225 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 9 | $195 |
| AstraZeneca Pharmaceuticals LP | 9 | $182 |
| CSL Behring | 4 | $134 |
| Medtronic, Inc. | 1 | $76 |
| BridgeBio Pharma, Inc. | 3 | $71 |
| SCPHARMACEUTICALS INC. | 3 | $66 |
| Merck Sharp & Dohme LLC | 3 | $63 |
| Daiichi Sankyo Inc. | 4 | $59 |
Products named: THORATEC HEARTMATE 3 LVAS IMPLANT KIT, LEQVIO, JARDIANCE, THORATEC HEARTMATE 3, Kcentra, WAINUA, Attruby, FUROSCIX.
Industry payments across NY — which companies pay providers there.
